Table 1. Immune memory responses of gamma delta (γδ) T cells.
BCG: Bacille Calmette-Guerin; CMV: Cytomegalovirus; HSV: herpes simplex virus; IMQ: imiquimod; MMR: measles-mumps-rubella; MPV: Mpox virus.
| Species | T cell subset | Experimental setting | Location | Adaptive immune memory responses | Innate immune memory responses | Ref | ||
|---|---|---|---|---|---|---|---|---|
| Inducing agent | Immune memory response characteristics | Inducing agent | Immune memory response characteristics | |||||
| Human and non-human primates | Vδ2 | In vitro | Peripheral blood | BCG | Enhanced proliferation upon M. tuberculosis stimulation | Hoft et al., 1998; Kabelitz et al., 1991 | ||
| Vδ2 | In vivo | Peripheral blood | BCG | Enhanced proliferation and IFN-γ production upon restimulation | Kabelitz et al., 1991 | |||
| γδ | In vivo | Pulmonary and peripheral blood | BCG | Enhanced proliferation upon reinfection | Shen et al., 2002; Lai et al., 2003 | |||
| Vδ2 | In vivo | Peripheral blood | Listeria monocytogenes | Enhanced proliferation and effector function upon reinfection | Ryan-Payseur et al., 2012 | |||
| γδ | In vivo | Peripheral blood | Plasmodium falciparum | Enhanced proliferation and IFN-γ production upon restimulation | Teirlinck et al., 2011 | |||
| Vδ1 | In vivo | Peripheral blood | Plasmodium falciparum | Clonal expansion, recurrent parasite-exposure driven expansion and differentiation | von Borstel et al., 2021; Rutishauser et al., 2020 | |||
| Vδ2 | In vivo | Peripheral blood | SARS-CoV-2 mRNA vaccine | Enhanced proliferation and IFN-γ production upon revaccination | Terzoli et al., 2024 | |||
| Vδ2 | In vivo | Peripheral blood | MPV | Enhanced proliferation and IFN-γ production upon rechallenge | Shao et al., 2009 | |||
| Vδ1 | In vivo | Peripheral blood | CMV | Rapid proliferation and infection resolution after reinfection | Pitard et al., 2008 | |||
| Vδ2 | In vivo | Pulmonary compartment | Listeria monocytogenes | Enhanced IFN-γ and perforin production; lower pulmonary pathology and less weight loss upon M. tuberculosis infection | Shen et al., 2019 | |||
| γδ | In vitro | Peripheral blood | BCG | Enhanced TNF and IFN-γ production upon C. albican challenge; transcriptional rewiring | Suen et al., 2024 | |||
| Vδ2 | In vitro | Peripheral blood | HSV | Enhanced lysing ability of infected cells upon PHA or mycobacteria stimulation | Bukowski et al., 1994 | |||
| γδ | In vitro | Peripheral blood | MMR | Enhanced TNF and IFN-γ production upon CD3 stimulation; transcriptional and metabolic rewiring | Röring et al., 2024 | |||
| Mouse | Vγ4Vδ1 | In vivo | Intestinal mucosa | Listeria monocytogenes | Enhanced proliferation and infection clearance upon rechallenge | Sheridan et al., 2013 | ||
| Vγ4 | In vivo | Intestinal epithelium | Listeria monocytogenes | Enhanced IL-17 production and clustering with L monocytogenes replication foci upon secondary infection | Romagnoli et al., 2016 | |||
| Vγ6 | In vivo | Peritoneum, draining mediastinal lymph nodes | Staphylococcus aureus | Enhanced IL-17 production and infection clearance after reinfection | Murphy et al., 2014 | |||
| Vγ6 | In vivo | Kidney | Staphylococcus aureus | Reduced renal bacterial load upon reinfection | Bertram et al., 2023 | |||
| Vγ1 | In vivo | Liver, lung, spleen | MCMV | Enhanced proliferation and survival rate upon rechallenge | Khairallah et al., 2015 | |||
| γδ | In vitro | Liver, spleen | Plasmodium chabaudi | Enhanced CD107a expression and IFN-γ production upon rechallenge; transcriptional reprogramming | Kumarasingha et al., 2020 | |||
| Vγ4Vδ4 | In vivo | Skin | IMQ | Enhanced proliferation and IL-17 production upon IMQ rechallenge | Ramírez-Valle et al., 2015 | |||
| Vγ4Vδ4 | In vivo | Skin; ear | IMQ | Enhanced proliferation and IL-17 production and neutrophil recruitment upon IMQ rechallenge | Hartwig et al., 2015 | |||
| Vγ4Vδ1 | In vitro | Gut; bulk mesenteric lymph nodes | Listeria monocytogenes | Enhanced proliferation and IFN-γ and IL-17A production upon S. enterica serovar Typhimurium and C. rodentium challenge | Khairallah et al., 2022 | |||
| Cow | γδ | In vitro | Airway and peripheral blood | BCG | Increased IFN-γ producing γδ T cells | Guerra-Maupome and McGill, 2019 | ||
| γδ | In vitro | Peripheral blood | BCG | Enhanced IL-6 and TNF production upon Escherichia coli, LPS and Pam3CSK4 stimulation; epigenetic rewiring | Samuel et al., 2024 | |||